Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dreier, J. P.
Right arrow Articles by Dirnagl, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dreier, J. P.
Right arrow Articles by Dirnagl, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 125, No. 1, 102-112, January 1, 2002
© 2002 Oxford University Press

Endothelin-1 potently induces Leão’s cortical spreading depression in vivo in the rat

A model for an endothelial trigger of migrainous aura?

Jens P. Dreier1,2, Jörg Kleeberg1,2, Gabor Petzold1,2, Josef Priller1,2, Olaf Windmüller1,2, Hans-Dieter Orzechowski3, Ute Lindauer1,2, Uwe Heinemann4, Karl M. Einhäupl2 and Ulrich Dirnagl1,2

Departments of 1Experimental Neurology, 2Neurology and 4Neurophysiology, Charité, Humboldt-University and 3Institute of Clinical Pharmacology and Toxicology, Benjamin Franklin Hospital, Free University of Berlin, Berlin, Germany Correspondence to: Jens P. Dreier, Department of Neurology, Charité, Humboldt Universität, Schumannstr. 20/21, 10117 Berlin, Germany E-mail: jens.dreier{at}charite.de

According to the ‘neuronal’ theory, cortical spreading depression (CSD) is the pathophysiological correlate of migrainous aura. However, the ‘vascular’ theory has implicated altered vascular function in the induction of aura symptoms. The possibility of a vascular origin of aura symptoms is supported, e.g. by the clinical observation that cerebral angiography frequently provokes migrainous aura. This suggests that endothelial irritation may somehow initiate one of the pathways resulting in migrainous aura. Up to now, an endothelium-derived factor has never been shown to trigger CSD. Here, for the first time, we demonstrate and characterize the ability of the vasoconstrictor and astroglial/neuronal modulator endothelin-1 to trigger Leão’s ‘spreading depression of activity’ in vivo in rats. At a concentration range between 10 nM and 1 µM, endothelin-1 induced changes characteristic of CSD with regard to the rate of propagation, steady (direct current) potential and extracellular K+-concentration. A spreading hyperaemia followed by oligaemia was observed similar to those in K+-induced CSD. Endothelin-1 did not provoke changes characteristic of a terminal depolarization. The mechanism by which endothelin-1 generated CSD involved the N-methyl-D-asparate receptor. Cerebral blood flow decreased slightly, but significantly, before endothelin-1 generated CSD. A vasodilator (NO·-donor) shifted the threshold for CSD induction to higher concentrations of endothelin-1. Endothelin-1, in contrast to K+, did not induce CSD in rat brain slices suggesting indirectly that endothelin-1 may require intact perfusion to exert its effects. In conclusion, endothelin-1 was found in the experiment to be the most potent inducer of CSD currently known. We propose endothelin-1 as a possible candidate for the yet enigmatic link between endothelial irritation and migrainous aura.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
G. E. Tietjen, N. A. Herial, L. White, C. Utley, J. M. Kosmyna, and S. A. Khuder
Migraine and Biomarkers of Endothelial Activation in Young Women
Stroke, September 1, 2009; 40(9): 2977 - 2982.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. A. Rogawski
Common Mechanisms in Migraine and Epilepsy: A Comment--Reply
Arch Neurol, November 1, 2008; 65(11): 1546 - 1547.
[Full Text] [PDF]


Home page
NeurologyHome page
J. M. Hansen, L. L. Thomsen, J. Olesen, and M. Ashina
Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype
Neurology, September 9, 2008; 71(11): 841 - 847.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. J. Strong, P. J. Anderson, H. R. Watts, D. J. Virley, A. Lloyd, E. A. Irving, T. Nagafuji, M. Ninomiya, H. Nakamura, A. K. Dunn, et al.
Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex
Brain, April 1, 2007; 130(4): 995 - 1008.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H. Hermans, M. C Post, V. Thijs, M. Spaepen, and W. I H L Budts
Increased prevalence of migraine in adult congenital heart disease
Heart, March 1, 2007; 93(3): 361 - 362.
[Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. P. Dreier, J. Kleeberg, M. Alam, S. Major, M. Kohl-Bareis, G. C. Petzold, I. Victorov, U. Dirnagl, T. P. Obrenovitch, and J. Priller
Endothelin-1-Induced Spreading Depression in Rats Is Associated with a Microarea of Selective Neuronal Necrosis
Experimental Biology and Medicine, February 1, 2007; 232(2): 204 - 213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
O. Kann and R. Kovacs
Mitochondria and neuronal activity
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C641 - C657.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Kleeberg, G. C. Petzold, S. Major, U. Dirnagl, and J. P. Dreier
ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1339 - H1346.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. C. Kruit, M. A. van Buchem, P. A. M. Hofman, J. T. N. Bakkers, G. M. Terwindt, M. D. Ferrari, and L. J. Launer
Migraine as a Risk Factor for Subclinical Brain Lesions
JAMA, January 28, 2004; 291(4): 427 - 434.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.